$9.1+ Billion Antacids Market Poised for Steady Growth: Key Trends and Projections to 2032
PORTLAND, OREGON, UNITED STATES, July 17, 2024 /EINPresswire.com/ -- ๐๐ง๐ช๐ฎ๐ข๐ซ๐ ๐๐๐๐จ๐ซ๐ ๐๐ฎ๐ฒ๐ข๐ง๐ : https://www.alliedmarketresearch.com/purchase-enquiry/A10281
Antacids Market Research, 2032
The global antacids market is projected to witness steady growth from $6.7 billion in 2022 to $9.1 billion by 2032, driven by various market dynamics and emerging trends.
Key Market Insights
โข Market Size and Growth:
โข 2022 Market Value: $6.7 billion
โข Projected 2032 Market Value: $9.1 billion
โข CAGR: 3.1% from 2023 to 2032
โข Antacid Functionality:
โข Neutralizes stomach acid.
โข Contains active ingredients like aluminum, calcium, magnesium, or sodium bicarbonate.
โข Treats symptoms such as acid reflux, heartburn, and indigestion.
Market Dynamics
โข Drivers:
โข Increasing prevalence of gastroesophageal reflux disease (GERD).
โข Rising awareness about digestive health.
โข Unhealthy eating habits and sedentary lifestyles.
โข Accessibility of over-the-counter (OTC) antacids.
โข Restraints:
โข Emergence of more effective treatments such as proton pump inhibitors (PPIs) and H2 receptor antagonists.
โข Opportunities:
โข Lifestyle changes leading to increased demand for antacids.
โข COVID-19 pandemic impact with increased gastrointestinal symptoms.
Segmental Overview
โข By Mechanism of Action:
โข Non-Systemic Antacids: Largest market share in 2022; fastest growth projected.
โข Systemic Antacids: Lesser market share due to consumer preference for non-systemic options.
โข By Formulation Type:
โข Tablets: Dominated market in 2022; popular for convenience and variety.
โข Liquids: Fastest growing segment; preferred for ease of use and palatability.
โข By Distribution Channel:
โข Drug Stores & Retail Pharmacies: Dominated market due to convenience.
โข Online Providers: Fastest growing segment; driven by e-commerce popularity.
Regional Analysis
โข North America:
โข Largest market share in 2022.
โข Growth driven by well-developed healthcare infrastructure and high prevalence of gastrointestinal diseases.
โข Asia-Pacific:
โข Highest growth rate projected.
โข Driven by increasing healthcare expenditure and growing awareness about heartburn and gastrointestinal issues.
Competitive Landscape
โข Major Players:
โข Abbott Laboratories
โข Alkem Laboratories Ltd.
โข Cipla Ltd.
โข Bayer AG
โข Haleon Plc
โข Infirst Healthcare Inc.
โข Pfizer Inc.
โข Prestige Consumer Healthcare Inc.
โข Reckitt Benckiser Group PLC
โข WellSpring Pharmaceutical Corporation
โข Other Important Players:
โข Major Pharmaceuticals
โข Topco Associates, LLC
๐๐ง๐ช๐ฎ๐ข๐ซ๐ ๐๐๐๐จ๐ซ๐ ๐๐ฎ๐ฒ๐ข๐ง๐ : https://www.alliedmarketresearch.com/purchase-enquiry/A10281
David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
X
![](https://www.einnews.com/tracking/article.gif?aid=728267963§ion=einpresswire&a=JbCHgR0b7PKk4wu7&i=E1aFz-YbhwDi7iaz)